(Q36939396)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17852027%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Rheumatoid arthritis and the complement system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17852027%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17852027%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Anna M. Blom

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17852027%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Dick Heinegård

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17852027%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Rikard Holmdahl

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17852027%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17852027%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17852027%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17852027%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17852027%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

517-530

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17852027%20AND%20SRC:MED&resulttype=core&format=json

Complement. Second of two parts

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

A key role of C5a/C5aR activation for the development of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Sublytic complement attack protects tumor cells from lytic doses of antibody and complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

The role of defective complement control in hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Complement and diseases: defective alternative pathway control results in kidney and eye diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

The role of complement in autoimmune renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Targeting C5a: recent advances in drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

C5b-9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Membrane complement regulatory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

The catalytically active serine protease domain of human complement factor I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Location and structure of the human FHR-5 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Anti-ischemia/reperfusion of C1 inhibitor in myocardial cell injury via regulation of local myocardial C3 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

C1-inhibitor and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Rheumatoid arthritis: inflammation and bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

The genetics of complex autoimmune diseases: non-MHC susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Genes, environment and immunity in the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Pathogenesis of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Autoantibodies in rheumatoid arthritis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

An analysis of the levels of complement components in the synovial fluid in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Observations on the microenvironmental nature of cartilage degradation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Markers of inflammatory activation: upregulation of complement receptors CR1 and CR3 on synovial fluid neutrophils from patients with inflammatory joint disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

A comparison of immunoglobulin G-containing high-molecular-weight complexes isolated from children with juvenile rheumatoid arthritis and congenital human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Cartilage specific collagen activates macrophages and the alternative pathway of complement: evidence for an immunopathogenic concept of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Mannan binding lectin and its interaction with immunoglobulins in health and in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Mannan-binding lectin and its role in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

The innate immune system in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Mannose-binding lectin engagement with late apoptotic and necrotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Animal models of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Genetic influences on the end-stage effector phase of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Arthritis critically dependent on innate immune system players

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

The Primary Structure of a Basic Leucine-rich Repeat Protein, PRELP, Found in Connective Tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Fibronectin fragments and their role in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

The C1q subunit of the first component of complement binds to laminin: a mechanism for the deposition and retention of immune complexes in basement membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Biology of fibrocartilage cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Cleavage of fibromodulin in cartilage explants involves removal of the N-terminal tyrosine sulfate-rich region by proteolysis at a site that is sensitive to matrix metalloproteinase-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

B cells in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Complement activation determines the therapeutic activity of rituximab in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Serious infections associated with anticytokine therapies in the rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Infection and musculoskeletal conditions: Bacterial and opportunistic infections during anti-TNF therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Problems encountered during anti-tumour necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Use of complement inhibitors in tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Structure-function relationships of complement receptor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

A review of current knowledge of the complement system and the therapeutic opportunities in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcgammaRIIb and is not associated with loci controlling diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Effects of FUT-175, a novel synthetic protease inhibitor, on the development of adjuvant arthritis in rats and some biological reactions dependent on complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546

Generation of a recombinant, membrane-targeted form of the complement regulator CD59: activity in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701477546